159 related articles for article (PubMed ID: 10540186)
1. Peripheral blood antigen-presenting cells from African-Americans exhibit increased CD80 and CD86 expression.
Hutchings A; Purcell WM; Benfield MR
Clin Exp Immunol; 1999 Nov; 118(2):247-52. PubMed ID: 10540186
[TBL] [Abstract][Full Text] [Related]
2. Differential expression and modulation of costimulatory molecules CD80 and CD86 on monocytes from patients with systemic lupus erythematosus.
Liu MF; Li JS; Weng TH; Lei HY
Scand J Immunol; 1999 Jan; 49(1):82-7. PubMed ID: 10023862
[TBL] [Abstract][Full Text] [Related]
3. [Costimulatory molecule expression on allergen-stimulated PBMC in cedar pollinosis subjects].
Morikawa H; Baba K
Nihon Jibiinkoka Gakkai Kaiho; 2001 Mar; 104(3):198-207. PubMed ID: 11305050
[TBL] [Abstract][Full Text] [Related]
4. CD80 (B7-1) and CD86 (B7-2) antigens on house dust mite-specific T cells in atopic disease function through T-T cell interactions.
Nakada M; Nishizaki K; Yoshino T; Okano M; Yamamoto T; Masuda Y; Ohta N; Akagi T
J Allergy Clin Immunol; 1999 Jul; 104(1):222-7. PubMed ID: 10400865
[TBL] [Abstract][Full Text] [Related]
5. Decreased inducible expression of CD80 and CD86 in human monocytes after ultraviolet-B irradiation: its involvement in inactivation of allogenecity.
Fujihara M; Takahashi TA; Azuma M; Ogiso C; Maekawa TL; Yagita H; Okumura K; Sekiguchi S
Blood; 1996 Mar; 87(6):2386-93. PubMed ID: 8630402
[TBL] [Abstract][Full Text] [Related]
6. Costimulatory molecules CD80 and CD86 in the rat; tissue distribution and expression by antigen-presenting cells.
Damoiseaux JG; Yagita H; Okumura K; van Breda Vriesman PJ
J Leukoc Biol; 1998 Dec; 64(6):803-9. PubMed ID: 9850164
[TBL] [Abstract][Full Text] [Related]
7. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
[TBL] [Abstract][Full Text] [Related]
8. Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus.
Wong CK; Lit LC; Tam LS; Li EK; Lam CW
Rheumatology (Oxford); 2005 Aug; 44(8):989-94. PubMed ID: 15870153
[TBL] [Abstract][Full Text] [Related]
9. CD80 and CD86 costimulatory molecules on circulating T cells of HIV infected individuals.
Köchli C; Wendland T; Frutig K; Grunow R; Merlin S; Pichler WJ
Immunol Lett; 1999 Feb; 65(3):197-201. PubMed ID: 10065743
[TBL] [Abstract][Full Text] [Related]
10. Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomas.
Chaperot L; Plumas J; Jacob MC; Bost F; Molens JP; Sotto JJ; Bensa JC
Exp Hematol; 1999 Mar; 27(3):479-88. PubMed ID: 10089910
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of the CD80 accessory molecule by alveolar macrophages in asthmatic subjects and its functional involvement in allergen presentation to autologous TH2 lymphocytes.
Burastero SE; Magnani Z; Confetti C; Abbruzzese L; Oddera S; Balbo P; Rossi GA; Crimi E
J Allergy Clin Immunol; 1999 Jun; 103(6):1136-42. PubMed ID: 10359896
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of costimulatory molecules in chronic inflammatory periodontal disease tissue.
Orima K; Yamazaki K; Aoyagi T; Hara K
Clin Exp Immunol; 1999 Jan; 115(1):153-60. PubMed ID: 9933436
[TBL] [Abstract][Full Text] [Related]
13. B7+ T cells in myeloma: an acquired marker of prior chronic antigen presentation.
Brown R; Murray A; Pope B; Sze D; Gibson J; Ho PJ; Joshua D
Leuk Lymphoma; 2004 Feb; 45(2):363-71. PubMed ID: 15101725
[TBL] [Abstract][Full Text] [Related]
14. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
[TBL] [Abstract][Full Text] [Related]
15. Functional expression of costimulatory molecule CD86 on epithelial cells in the inflamed colonic mucosa.
Nakazawa A; Watanabe M; Kanai T; Yajima T; Yamazaki M; Ogata H; Ishii H; Azuma M; Hibi T
Gastroenterology; 1999 Sep; 117(3):536-45. PubMed ID: 10464129
[TBL] [Abstract][Full Text] [Related]
16. FcR cross-linking on monocytes results in impaired T cell stimulatory capacity.
Barcy S; Wettendorff M; Leo O; Urbain J; Kruger M; Ceuppens JL; de Boer M
Int Immunol; 1995 Feb; 7(2):179-89. PubMed ID: 7537534
[TBL] [Abstract][Full Text] [Related]
17. Increased costimulatory responses in African-American kidney allograft recipients.
Hutchings A; Purcell WM; Benfield MR
Transplantation; 2001 Mar; 71(5):692-5. PubMed ID: 11292304
[TBL] [Abstract][Full Text] [Related]
18. Expression of costimulatory molecules on peripheral blood mononuclear cells in multiple sclerosis.
Mena E; Rohowsky-Kochan C
Acta Neurol Scand; 1999 Aug; 100(2):92-6. PubMed ID: 10442449
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of B7-1 (CD80) and B7-2 (CD86) costimulatory molecules and dendritic cells on the immune response in leprosy.
Santos DO; Santos SL; Esquenazi D; Nery JA; Defruyt M; Lorré K; Van Heuverswyn H
Nihon Hansenbyo Gakkai Zasshi; 2001 Feb; 70(1):15-24. PubMed ID: 11244783
[TBL] [Abstract][Full Text] [Related]
20. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G
Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
